Stimulant Use Disorders: Overview and Current Trends


Stimulant Use Disorders: Overview and Current Trends Banner



Date & Location
Thursday, February 20, 2025, 8:00 AM - Thursday, February 19, 2026, 11:00 PM

Target Audience
Specialties - Patient Safety and Quality
Professions - Pharmacist, Pharmacy Technician

Overview

The Indianapolis Coalition for Patient Safety (ICPS) is hosting a series of webinars to provide health care givers with up-to-date information related to Substance Use Disorder (SUD).

Launch Date: 2/20/2025

Expiration Date: 2/19/2026

A copy of the slides are available by reaching out to Jim Fuller at [email protected].


Objectives
At the conclusion of this activity, participants should be able to:

  1. Discuss current trends in the opioid epidemic
  2. Recognize the history and context of changing language around Substance Use Disorder and it's effect on stigma
  3. Recognize available local resources and trends in identification and treatment of patients with Substance Use Disorder

Registration

How to obtain CE credits:

Please note, you have to watch the entire video in order to receive any CE credit for this online activity.
Sign in or create a new account by clicking "Sign In" in top left corner. *If you previously participated in a CME activity accredited by IUSM  but do not know your password, please enter your email address and click on the 'Forget Your Password' link. Your password will be emailed to you.

  1. Click the Tests tile > Launch Video to view the module.
  2. After viewing the video go back to the Tests tile and click Post-Test to attest to completing the activity.
  3. Click the MyCME button > Evaluations and Certificates.
  4. Find the activity name in the list and click Complete Evaluation.
  5. Click Submit.
  6. On the Evaluations and Certificates page, click Download Certificate or access your transcript through the Transcript tile.

Please note that you are not able to claim credit if you already attended the live virtual conference on February 12th, 2025.


Accreditation
 
In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and Indianapolis Coalition for Patient Safety. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses
Indiana University School of Medicine designates this activity for a maximum of 1.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
Indiana University School of Medicine designates this activity for 1.0 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Physicians
Indiana University School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Social Workers
Indiana University School of Medicine has been approved by the Indiana Social Worker, Marriage and Family Therapist and Mental Health Counselor Board to provide Category I Continuing Education program. This activity qualifies for 1.0 Category I CEU as outlined by the Indiana Behavioral Health and Human Services Licensing Board.

References:

The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. Journal of Addiction Medicine 18(1S):p 1-56, May/June 2024. DOI: 10.1097/ADM.0000000000001299

Stimulant Use Disorder Guideline SAMHSA 

2023 NSDUH Annual National Report | CBHSQ Data SAMHSA

Figure - PMC

Drug Fact Sheet: Stimulants DEA

Ciccarone D. Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment Attempts at Pharmacotherapy. Prim Care. 2011 March. 38(1): 41-58. doi: 10.1016/j.pop.2010.11.004

Siefried KJ, Acheson L, Cliffod B, et al. Protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use (the NABU trial). BMJ Open 2025:15:e092032, doi:10.1136/bmjopen-2024-092032.

Suen et al, Presecribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape. J Addict Med. Volume 00, Number 00, 2025: 1-3


Additional Information

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.


Credits
AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), ACPE Contact Hours (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Attendance (1.00 hours), Social Work Category I CEU (1.00 hours)